Abstract:Abstract Background Long non-coding RNAs (lncRNAs) are extensively intricate in the tumorigenesis and metastasis of various cancer types. Nevertheless, the detailed molecular mechanisms of lncRNA in non-small cell lung cancer (NSCLC) still remain mainly undetermined. Methods qPCR was performed to verify LINC00301 expression in NSCLC clinical specimens or cell lines. Fluorescence in situ hybridization (FISH) was conducted to identify the localization of LINC00301 in NSCLC cells. Chromatin immunoprecipitation (ChIP) was subjected to validate the binding activity between FOXC1 and LINC00301 promoters. RNA immunoprecipitation (RIP) was performed to explore the binding activity between LINC00301 and EZH2. RNA pull-down followed by dot-blot, protein domain mapping, and RNA electrophoresis mobility shift assay (EMSA) were conducted to identify the detailed binding regions between LINC00301 and EZH2. Alpha assay was conducted to quantitatively assess the interaction between LINC00301 and EZH2. Results LINC00301 is highly expressed in NSCLC and closely corelated to its prognosis by analyzing the relationship between differentially expressed lncRNAs and prognosis in NSCLC samples. in vitro and in vivo experiments revealed that LINC00301 facilitates cell proliferation, releases NSCLC cell cycle arrest, promotes cell migration and invasion, and suppresses cell apoptosis in NSCLC. In addition, LINC00301 increases regulatory T cell (Treg) while decreases CD8 + T cell population in LA-4/SLN-205-derived tumors through targeting TGF-β. The transcription factor FOXC1 mediates LINC00301 expression in NSCLC. Bioinformatics prediction and in vitro experiments indicated that LINC00301 (83–123 nucleotide [nt]) can directly bind to the enhancer of zeste homolog 2 (EZH2) (612–727 amino acid [aa]) to promote H3K27me3 at the ELL protein - associated factor 2 ( EAF2 ) promoter. EAF2 directly binds and stabilizes von Hippel–Lindau protein (pVHL), so downregulated EAF2 augments hypoxia-inducible factor 1 α (HIF1α) expression by regulating pVHL in NSCLC cells. Moreover, we also found that LINC00301 could function as a competing endogenous RNA (ceRNA) against miR-1276 to expedite HIF1α expression in the cytoplasm of NSCLC cells. Conclusions In summary, our present research revealed the oncogenic roles of LINC00301 in clinical specimens as well as cellular and animal experiments, illustrating the potential roles and mechanisms of the FOXC1/LINC00301/EZH2/EAF2/pVHL/HIF1α and FOXC1/LINC00301/miR-1276/HIF1α pathways, which provides novel insights and potential theraputic targets to NSCLC.

Overexpression of ELF3 Facilitates Cell Growth and Metastasis Through PI3K/Akt and ERK Signaling Pathways in Non-Small Cell Lung Cancer

LncRNA ELF3-AS1 Promotes Non-Small Cell Lung Cancer Cell Invasion and Migration by Downregulating miR-212.

Ehf Enhances Malignancy By Modulating Akt And Mapk/Erk Signaling In Non-Small Cell Lung Cancer Cells

ELF3 is an Antagonist of Oncogenic-Signalling-induced Expression of EMT-TF ZEB1

LncRNA SNHG3 is Activated by E2F1 and Promotes Proliferation and Migration of Non‐small‐cell Lung Cancer Cells Through Activating TGF‐β Pathway and IL‐6/JAK2/STAT3 Pathway

EGF Upregulates RFPL3 and Htert Via the MEK Signaling Pathway in Non‑small Cell Lung Cancer Cells.

ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer

Expression and Gene Regulation Network of ELF3 in Breast Invasive Carcinoma Based on Data Mining.

NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target

NEIL3 Promotes Cell Proliferation of Ccrcc Via the Cyclin D1-Rb-E2F1 Feedback Loop Regulation.

FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer

FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC

An Autocrine IL-6/IGF-1R Loop Mediates EMT and Promotes Tumor Growth in Non-small Cell Lung Cancer

FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

The effect of Phosphoinositide-3-kinase, regulatory subunit 3 in epithelial-mesenchymal transition and migration of non-small cell lung cancer

ERO1L promotes NSCLC development by modulating cell cycle‐related molecules

HS3ST3B1 is a Novel Regulator of TGF-Beta Mediated EMT and Regulated by Mir-218 in Non-Small Cell Lung Cancer

Diagnostic and Prognostic Potentials of Long Noncoding RNA ELF3-AS1 in Glioma Patients

LEF1/Id3/HRAS Axis Promotes the Tumorigenesis and Progression of Esophageal Squamous Cell Carcinoma.

MEX3A promotes the proliferation, migration, and invasion of non-small-cell lung cancer by activating the MEK/ERK pathway.

METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2